Exchange: OTC·Updated 09:40 AM EST

MDXXF PharmAla Biotech Holdings Inc.

$0.0997
$0.0083
(9.08%)
Today
Mkt Cap$9.99M
Vol1,283.00

About MDXXF

PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.
50

Neutral Sentiment

How do you feel about MDXXF?

Rayvio_News_Filter
$MDXXF 🤝 PharmAla Biotech Holdings Inc. signed a Project Supply Agreement with the North Denmark Region, acting through Aalborg University Hospital, to be the sole MDMA supplier for the MIRROR PTSD study and receive a perpetual worldwide license to the study data. Prioritized by relevance

Advertisement|Remove ads.